Literature DB >> 20450274

Factors affecting outcome following treatment of patients with cavernous sinus meningiomas.

Michael E Sughrue1, Martin J Rutkowski, Derick Aranda, Igor J Barani, Michael W McDermott, Andrew T Parsa.   

Abstract

OBJECT: Although there is a considerable volume of literature available on the treatment of patients with cavernous sinus meningiomas (CSMs), most of the data regarding tumor control and survival come from case studies or single-institution series. The authors performed a meta-analysis of reported tumor control and survival rates of patients described in the published literature, with an emphasis on specific prognostic factors.
METHODS: The authors systematically analyzed the published literature and found more than 3000 patients treated for CSMs. Separate meta-analyses were performed to calculate pooled rates of recurrence and cranial neuropathy after 1) gross-total resection, 2) subtotal resection without adjuvant postoperative radiotherapy or radiosurgery, and 3) stereotactic radiosurgery (SRS) alone. Results were expressed as pooled proportions, and random-effects models were used to incorporate any heterogeneity present to generate a pooled proportion. Individual studies were weighted using the inverse variance method, and 95% CIs for each group were calculated from the pooled proportions.
RESULTS: A total of 2065 nonduplicated patients treated for CSM met inclusion criteria for the analysis. Comparisons of the 95% CIs for recurrence of these 3 cohorts revealed that SRS-treated patients experienced improved rates of recurrence (3.2% [95% CI 1.9-4.5%]) compared with either gross-total resection (11.8% [95% CI 7.4-16.1%]) or subtotal resection alone (11.1% [95% CI 6.6-15.7%]) (p < 0.01). The authors found that the pooled mixed-effects rate of cranial neuropathy was markedly higher in patients undergoing resection (59.6% [95% CI 50.3-67.5%]) than for those undergoing SRS alone (25.7% [95% CI 11.5-38.9%]) (p < 0.05).
CONCLUSIONS: Radiosurgery provided improved rates of tumor control compared with surgery alone, regardless of the subjective extent of resection.

Entities:  

Mesh:

Year:  2010        PMID: 20450274     DOI: 10.3171/2010.3.JNS091807

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  17 in total

1.  Hypofractionated stereotactic radiation therapy in skull base meningiomas.

Authors:  Pierina Navarria; Federico Pessina; Luca Cozzi; Elena Clerici; Elisa Villa; Anna Maria Ascolese; Fiorenza De Rose; Tiziana Comito; Ciro Franzese; Giuseppe D'Agostino; Francesca Lobefalo; Antonella Fogliata; Giacomo Reggiori; Maurizio Fornari; Stefano Tomatis; Lorenzo Bello; Marta Scorsetti
Journal:  J Neurooncol       Date:  2015-06-04       Impact factor: 4.130

2.  A review of stereotactic radiosurgery practice in the management of skull base meningiomas.

Authors:  Elena Vera; J Bryan Iorgulescu; Daniel M S Raper; Karthik Madhavan; Brian E Lally; Jacques Morcos; Samy Elhammady; Jonathan Sherman; Ricardo J Komotar
Journal:  J Neurol Surg B Skull Base       Date:  2014-03-12

3.  Cavernous Sinus Meningioma with Orbital Involvement: Algorithmic Decision-Making and Treatment Strategy.

Authors:  Amol Raheja; William T Couldwell
Journal:  J Neurol Surg B Skull Base       Date:  2020-09-17

4.  WHO grade of intracranial meningiomas differs with respect to patient's age, location, tumor size and peritumoral edema.

Authors:  Anne Ressel; Susanne Fichte; Michael Brodhun; Steffen K Rosahl; Ruediger Gerlach
Journal:  J Neurooncol       Date:  2019-10-01       Impact factor: 4.130

5.  Long-term outcomes of stereotactic radiosurgery for skull base tumors involving the cavernous sinus.

Authors:  Motoyuki Umekawa; Yuki Shinya; Hirotaka Hasegawa; Masahiro Shin; Mariko Kawashima; Atsuto Katano; Nobuhito Saito
Journal:  J Neurooncol       Date:  2022-01-14       Impact factor: 4.130

Review 6.  The cavernous sinus meningiomas' dilemma: Surgery or stereotactic radiosurgery?

Authors:  Laura Fariselli; Antonio Biroli; Antonio Signorelli; Morgan Broggi; Marcello Marchetti; Francesco Biroli
Journal:  Rep Pract Oncol Radiother       Date:  2015-06-03

7.  High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539.

Authors:  C Leland Rogers; Minhee Won; Michael A Vogelbaum; Arie Perry; Lynn S Ashby; Jignesh M Modi; Anthony M Alleman; James Galvin; Shannon E Fogh; Emad Youssef; Nimisha Deb; Young Kwok; Clifford G Robinson; Hui-Kuo Shu; Barbara J Fisher; Valerie Panet-Raymond; William G McMillan; John F de Groot; Peixin Zhang; Minesh P Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-11-29       Impact factor: 7.038

8.  Stereotactic Radiosurgery of Cavernous Sinus Meningiomas.

Authors:  Daniel Rueß; Fenja Fritsche; Stefan Grau; Harald Treuer; Mauritius Hoevels; Martin Kocher; Christian Baues; Maximilian I Ruge
Journal:  J Neurol Surg B Skull Base       Date:  2019-03-12

9.  Long-term evaluation of the effect of hypofractionated high-energy proton treatment of benign meningiomas by means of (11)C-L-methionine positron emission tomography.

Authors:  Mats Ryttlefors; Torsten Danfors; Francesco Latini; Anders Montelius; Erik Blomquist; Olafur Gudjonsson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-28       Impact factor: 9.236

10.  Cranial nerve outcomes after primary stereotactic radiosurgery for symptomatic skull base meningiomas.

Authors:  Andrew Faramand; Hideyuki Kano; Ajay Niranjan; Stephen A Johnson; Mohab Hassib; Kyung-Jae Park; Yoshio Arai; John C Flickinger; L Dade Lunsford
Journal:  J Neurooncol       Date:  2018-04-24       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.